The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Jun 2018 16:18

RNS Number : 2445Q
Circassia Pharmaceuticals Plc
04 June 2018
 

Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification

 

4 June 2018: Circassia Pharmaceuticals plc (LSE: CIR).

 

 

1 - Details of the person discharging managerial responsibilities/person closely associated

 

Name

Julien Cotta

 

2 - Reason for the notification

 

Position/status

Chief Financial Officer (PDMR)

Initial notification/amendment*

Initial Notification

In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending

N/A

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Full name of entity*

Circassia Pharmaceuticals plc

Legal Entity Identifier code

2138006YAT138TOGA556

In accordance with ISO 1744 LEI code

 

4 - Details of the transaction(s)

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

Date

Description of Financial Transaction

Aggregated Price

Aggregated Volume

Total Aggregated Price

31-May-18

Grant of options under the 2018 Share Option scheme.

£0.0008

250,000

£200

 

 

i. Award of options

 

Description of the financial instrument, type of instrument

Circassia Pharmaceuticals Plc 2018 Performance Share Plan

Identification Code

N/A

Nature of the transaction

Award of options

Currency

GBP

Price(s) and Volume (s)

Price

Volume

Total

£0.0008p

250,000

£200

Aggregated Information

Price

Volume

Total

£0.0008p

250,000

£200

Date of Transaction

31 May 2018

Place of Transaction

London: XLON

 

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDLUBGBGIS
Date   Source Headline
17th Aug 20059:43 amRNSDirectorate Changes
18th Jul 200511:04 amRNSSAR 3 - Capricorn Resources
15th Jul 20054:36 pmRNSBoard changes & shareholdings
30th Jun 20057:00 amRNSFinal Results
19th Apr 20052:16 pmRNSAdditional Listing
7th Feb 20052:33 pmRNSPossible acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.